Advertisement
Organisation › Details
InSphero (Group)
InSphero is the pioneer of industrial-grade, 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology. Through partnerships, InSphero supports pharmaceutical and biotechnology researchers in successful decision-making by accurately rebuilding the human physiology in vitro. Its robust and precisely engineered suite of 3D InSight™ human tissue platforms are used by major pharmaceutical companies worldwide to increase efficiency in drug discovery and safety testing. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and oncology (with a focus on immuno-oncology and PDX models). The scalable Akura™ technology underlying the company’s 3D InSight™ Discovery and Safety Platforms includes 96 and 384-well plate formats and the Akura™ Flow organ-on-a-chip system to drive efficient innovation throughout all phases of drug development. *
Start | 2009-01-01 splitoff | |
Predecessor | ETH Zürich, Dept. of Biosystems Science and Engineering (D-BSSE, Basel) | |
Industry | cell-based assay (research) | |
Person | Lichtenberg, Jan (InSphero 201401 CEO + Co-founder) | |
Person 2 | Strube, Randy (InSphero 201401– Director of Global Marketing) | |
Region | Schlieren ZH | |
Country | Switzerland | |
Street | 27 Wagistr. | |
City | 8952 Schlieren ZH | |
Tel | +41-44-515049-0 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | A: 1 to 10 (2011-04-28) |
* Document for »About Section«: InSphero AG. (1/19/23). "Press Release: Brenus Pharma and InSphero Receive €1.5 Million in Grants from the European EUROSTARS Fund". Lyon & Schlieren. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for InSphero (Group)
- [1] InSphero AG. (12/14/23). "Press Release: InSphero Strengthens Its Executive Team by Appointing Paul Clémençon, MBA as Chief Business Officer". Zürich....
- [2] Scailyte AG. (5/9/23). "Press Release: Jan Lichtenberg Joins Scailyte’s Board of Directors"....
- [3] InSphero AG. (3/31/23). "Press Release: InSphero Accelerates Launch of Cryopreserved 3D Microtissue Platform with New Investment Round Led by Zeiss Ventures". Zürich....
- [4] InSphero AG. (3/13/23). "Press Release: Vrije Universiteit Brussel (VUB) and InSphero Partner to Advance Drug Discovery for Non-Alcoholic Steatohepatitis". Schlieren....
- [5] InSphero AG. (1/19/23). "Press Release: Brenus Pharma and InSphero Receive €1.5 Million in Grants from the European EUROSTARS Fund". Lyon & Schlieren....
- [6] InSphero AG. (10/26/17). "Press Release: InSphero and Charles River Announce PDX Partnership". Schlieren....
- [7] InSphero AG. (10/18/17). "Press Release: InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting in Washington, DC". Schlieren....
- [8] InSphero AG. (3/27/17). "Press Release: InSphero 3D Liver Microtissues Featured at Annual SOT Meeting as More Sensitive Model for DILI and Mechanistic Toxicity Testing". Schlieren....
- [9] InSphero AG. (3/16/17). "Press Release: InSphero Launches 3D InSight Monkey Liver Microtissues at Annual Society of Toxicology Meeting". Schlieren....
- [10] InSphero AG. (2/2/17). "Press Release: InSphero to Introduce GravityTRAP 384 Microtissue Platform at SLAS2017". Schlieren....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top